COVID-19 | Discover the latest peer-reviewed research articles from the Eastern Mediterranean Region
COVID-19 | Discover the latest peer-reviewed research articles from the Eastern Mediterranean Region
COVID-19 | Discover the latest publications published by WHO Regional Office for the Eastern Mediterranean
COVID-19 | Discover the latest publications published by WHO Regional Office for the Eastern Mediterranean

Virtual Health Sciences Library

  • Home
  • Search
  • Knowledge Base
  • Get a journal indexed in the Index Medicus
  • MyVHSL
  1. Home
  2. IMEMR
  3. Search Result
  4. Comparative study of dermaroller therapy versus trichloroacetic acid CROSS for the treatment of atrophic acne scars

Comparative study of dermaroller therapy versus trichloroacetic acid CROSS for the treatment of atrophic acne scars

Authors

Puri Neerja
Guru Gobind Singh Medical College and Hospital ; ,

J. Pak. Assoc. Dermatol. 2015; 25 (2): 114-118
JPAD-Journal of Pakistan Association of Dermatologists
Journal Country: Pakistan
P-ISSN: 1560-9014
E-ISSN: 2413-7650
Type of Publication: Comparative study
Category: Adult, Adolescent, Child, Female, Humans, Male,
Type of Research: Clinical
Keywords: Acne Vulgaris / Therapy
Broad Subjects: Health Systems, Cicatrix ,Trichloroacetic Acid
Citation: Neerja Puri , Comparative study of dermaroller therapy versus trichloroacetic acid CROSS for the treatment of atrophic acne scars, J. Pak. Assoc. Dermatol. 2015; 25 (2): 114-118

Abstract English

To compare the efficacy and safety of dermaroller treatment with that of TCA CROSS in acne scars. We selected thirty patients of atrophic acne scars for the study. Group I patients underwent four sessions of dermaroller therapy four weeks apart. Group II were treated with four sessions of TCA CROSS technique four weeks apart. After four sessions of dermaroller and TCA CROSS each, marked improvement was seen in 40% patients in the dermaroller group and in 60% patients in the CROSS group. Moderate improvement was seen in 40% patients in dermaroller group and in 26.6% patients in the CROSS group and mild improvement was seen in 20% patients in dermaroller group and 13.3% patients in the CROSS group. Side effects were mild and infrequent in both groups. Both treatments are equally effective and safe for the treatment of acne scars

Full Text English

Subscribe to VHSL Newsletters

© 2020 WHO – EMRO